营养补充剂治疗脱发的安全性和有效性评价:一项系统综述
该系统综述检索MEDLINE、Embase和CINAHL数据库(自建库至2021年10月20日),纳入30篇文章(17项随机临床试验、11项非随机临床研究、2项病例系列研究),评估无已知基线营养缺乏的脱发者使用膳食与营养干预的安全性和有效性。质量最高的证据显示Viviscal、Nourkrin、Nutrafol、Lamdapil、Pantogar、辣椒素与异黄酮、ω-3与ω-6联合抗氧化剂、苹果营养制剂、白芍总苷与复方甘草酸苷片、锌、生育三烯酚和南瓜籽油可能获益;所有评估疗法的副作用罕见且轻微。
要点
- 质量最高的证据显示Viviscal、Nourkrin、Nutrafol等多种营养补充剂对脱发可能有益。
- 泡菜与清麴酱、维生素D3和Forti5改善疾病病程的证据质量低。
- 所有评估疗法的副作用罕见且轻微,医师应与患者共同决策。
核心结论
- 该系统综述提示营养补充剂在脱发治疗中可能发挥作用,但结果应结合各研究设计解读。
- 医师应与脱发患者共同决策,告知这些治疗的潜在风险与获益。
- 未来研究应聚焦于设主动对照的更大规模随机临床试验。
研究设计与样本
- 系统综述检索MEDLINE、Embase和CINAHL数据库,自建库至2021年10月20日,限英文文献。
- 纳入无已知基线营养缺乏的脱发或脱发者膳食与营养干预的原始研究文章。
- 数据库检索获6347条引文,另从参考文献列表补充11篇,最终纳入30篇:17项随机临床试验、11项非随机临床研究、2项病例系列研究。
- 无符合纳入标准的膳食干预研究;质量按牛津循证医学中心标准评估。
- 数据评估时间为2022年1月3日至11日。
主要发现
- 质量最高的证据显示Viviscal、Nourkrin、Nutrafol、Lamdapil、Pantogar、辣椒素与异黄酮、ω-3与ω-6联合抗氧化剂、苹果营养制剂、白芍总苷与复方甘草酸苷片、锌、生育三烯酚和南瓜籽油可能有益。
- 泡菜与清麴酱、维生素D3和Forti5改善疾病病程的证据质量低。
- 所有评估疗法的副作用罕见且轻微。
临床怎么用
- 作者认为营养补充剂在脱发治疗中可能发挥作用,但应结合各研究设计解读结果。
- 作者建议医师与脱发患者共同决策,告知这些治疗的潜在风险与获益。
- 作者建议未来研究聚焦于设主动对照的更大规模随机临床试验。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Despite the widespread use of nutritional supplements and dietary interventions for treating hair loss, the safety and effectiveness of available products remain unclear. OBJECTIVE: To evaluate and compile the findings of all dietary and nutritional interventions for treatment of hair loss among individuals without a known baseline nutritional deficiency. EVIDENCE REVIEW: The MEDLINE, Embase, and CINAHL databases were searched from inception through October 20, 2021, to identify articles written in English with original findings from investigations of dietary and nutritional interventions in individuals with alopecia or hair loss without a known baseline nutritional deficiency. Quality was assessed with Oxford Centre for Evidence Based Medicine criteria. Outcomes of interest were disease course, both objectively and subjectively measured. Data were evaluated from January 3 to 11, 2022. FINDINGS: The database searches yielded 6347 citations to which 11 articles from reference lists were added. Of this total, 30 articles were included: 17 randomized clinical trials (RCTs), 11 clinical studies (non-RCT), and 2 case series studies. No diet-based interventional studies met inclusion criteria. Studies of nutritional interventions with the highest-quality evidence showed the potential benefit of Viviscal, Nourkrin, Nutrafol, Lamdapil, Pantogar, capsaicin and isoflavone, omegas 3 and 6 with antioxidants, apple nutraceutical, total glucosides of paeony and compound glycyrrhizin tablets, zinc, tocotrienol, and pumpkin seed oil. Kimchi and cheonggukjang, vitamin D3, and Forti5 had low-quality evidence for disease course improvement. Adverse effects were rare and mild for all the therapies evaluated. CONCLUSIONS AND RELEVANCE: The findings of this systematic review should be interpreted in the context of each study's design; however, this work suggests a potential role for nutritional supplements in the treatment of hair loss. Physicians should engage in shared decision-making by covering the potential risks and benefits of these treatments with patients experiencing hair loss. Future research should focus on larger RCTs with active comparators.
引用
- Drake L, Reyes-Hadsall S, Martinez J, et al. Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss: A Systematic Review. JAMA Dermatol. 2023. PMID: 36449274. doi:10.1001/jamadermatol.2022.4867
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。